Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Canadian-under $3.00 Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: Ceedee who wrote (10950)	1/17/2003 10:56:44 PM
From: Al Collard	Respond to of 11802

Hi Ceedee, Your in with CJC-t @$ .42 for 23,809 shares. Chart for ConjuChem Inc: stockcharts.com[w,a]dacaniay[dc][pc20!b50!f][vc60][iLa12,26,9!Lh14,3]&pref=G From the chart of CJC we can see the stock has been going sideways for the last four months. On Friday the stock broke atop it's 20EMA, a bullish signal. The long white candlestick with above average volume shows the bulls have gained the momentum. The last two candlesticks have formed a bullish engulfing pattern, suggesting a change in trend is imminent. (Buy) Good luck with this pick, Al

To: Ceedee who wrote (10950)	1/20/2003 10:08:20 PM
From: Al Collard	Respond to of 11802

CJC-t...in the news: Conjuchem stock sold by Fidelity Mon 20 Jan 2003 News Release Ms. Kim Flood of Fidelity reports FIDELITY SELLS SHARES OF CONJUCHEM INC. Certain fund accounts for which Fidelity Management & Research Company of 82 Devonshire St., Boston, Mass., serves as investment adviser have sold 659,000 shares (or 2.40 per cent) of Conjuchem common stock. Fidelity had control but not ownership of these shares. As a result of the purchase, Fidelity holds two million shares (or 7.30 per cent) of Conjuchem's common stock. Fidelity's sale of Conjuchem's common stock was executed on the Toronto Stock Exchange. Fidelity fund account sales have been made for investment purposes only, and not with the purpose of influencing the control or direction of Conjuchem. The Fidelity fund accounts may, subject to market conditions, make additional investments in or dispositions of securities of Conjuchem, including additional purchases of shares of common stock. Fidelity does not, however, intend to acquire 20 per cent of any class of the outstanding voting or equity securities of Conjuchem.